<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04052581</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00220604</org_study_id>
    <nct_id>NCT04052581</nct_id>
  </id_info>
  <brief_title>Prospective Collection of Outcome Data Post POEM-TIF Procedure</brief_title>
  <official_title>Assessment of Safety and Outcomes in Patients Undergoing a Standard-of-care Combined POEM-TIF Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Per Oral Endoscopic Myotomy has been established as a safe and effective treatment of&#xD;
      Achalasia type I and II; however, it is limited by post-procedure gastroesophageal reflux.&#xD;
      Transoral Incisionless Fundoplication (TIF) has been introduced as the endoscopic gold&#xD;
      standard for anti-reflux procedure. Recently, combined POEM-TIF has been performed&#xD;
      successfully as a standard of care treatment for patients with severe GER after POEM. We aim&#xD;
      to study the safety and feasibility of performing POEM-TIF (POEM and TIF in the same&#xD;
      endoscopic session). This study will also put the groundwork for a randomized clinical trial&#xD;
      to further study the clinical outcome of the POEM-TIF procedure.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Safety of POEM-TIF as assessed by the American Society of Gastrointestinal Endoscopy (ASGE) lexicon scoring system</measure>
    <time_frame>6 months</time_frame>
    <description>Safety will be evaluated by the frequency of severe adverse events with probable or definite attribution to the procedure based the ASGE lexicon scoring system. ASGE lexicon's severity grading system classify the adverse events into one of the four categories of mild, moderate, severe, and fatal. Mild adverse event means an adverse event that result in (1) Procedure aborted (or not started) because of an adverse event, (2) Post-procedure medical consultation, or (3) Unplanned hospital admission or prolongation of hospital stay for lesser or equal to 3 nights. Fatal grade adverse event happens when the procedure cause death.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Achalasia</condition>
  <condition>Gastroesophageal Reflux Disease</condition>
  <arm_group>
    <arm_group_label>POEM-TIF</arm_group_label>
    <description>All participants will undergo the POEM-TIF in the same session.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>POEM-TIF</intervention_name>
    <description>Transoral Incisionless Fundoplication (TIF) following Per oral Endoscopic Myotomy (POEM) in the same session</description>
    <arm_group_label>POEM-TIF</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patient age &gt; 18 years old who have been diagnosis with either type I or type II&#xD;
        Achalasia that has been proved by manometry&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patient age greater than 18 years old&#xD;
&#xD;
          -  Manometrically proven diagnosis of either type I or type II achalasia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Achalasia type III, or other esophageal dysmotility disorders.&#xD;
&#xD;
          -  Completion of POEM with evidence of mucosal injury or compromise&#xD;
&#xD;
          -  Previous surgery of the stomach such as sleeve gastrectomy, gastric bypass, Heller&#xD;
             myotomy, partial or complete fundoplication, or partial/complete gastrectomy&#xD;
&#xD;
          -  Esophageal lumen diameter greater than 4 cm&#xD;
&#xD;
          -  Sigmoidization of the esophagus&#xD;
&#xD;
          -  Large esophageal diverticula&#xD;
&#xD;
          -  Known active gastroesophageal malignancy&#xD;
&#xD;
          -  Inability to tolerate sedated upper endoscopy due to cardiopulmonary instability,&#xD;
             severe pulmonary disease or other contraindication to endoscopy&#xD;
&#xD;
          -  Cirrhosis with portal hypertension, varices, and/or ascites&#xD;
&#xD;
          -  Pregnant or breastfeeding women (all women of child-bearing age will undergo urine&#xD;
             pregnancy testing)&#xD;
&#xD;
          -  Acute gastrointestinal bleeding&#xD;
&#xD;
          -  Uncorrectable coagulopathy defined by international normalized ratio (INR) &gt; 1.5 or&#xD;
             platelet &lt; 50,000&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mouen Khashab</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mouen Khashab</last_name>
    <phone>443-287-1960</phone>
    <email>mkhasha1@jhmi.edu</email>
  </overall_contact>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 8, 2019</study_first_submitted>
  <study_first_submitted_qc>August 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 12, 2019</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Per oral Endoscopic Myotomy</keyword>
  <keyword>Transoral Incisionless Fundoplication</keyword>
  <keyword>POEM</keyword>
  <keyword>TIF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

